327 related articles for article (PubMed ID: 23196650)
1. Intraocular lymphoma: a clinical perspective.
Davis JL
Eye (Lond); 2013 Feb; 27(2):153-62. PubMed ID: 23196650
[TBL] [Abstract][Full Text] [Related]
2. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostics and treatment of primary vitreoretinal lymphoma].
Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
Rajagopal R; Harbour JW
Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
[TBL] [Abstract][Full Text] [Related]
5. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma.
Chan CC; Sen HN
Discov Med; 2013 Feb; 15(81):93-100. PubMed ID: 23449111
[TBL] [Abstract][Full Text] [Related]
6. Primary Vitreoretinal Lymphoma -- A Review.
Araujo I; Coupland SE
Asia Pac J Ophthalmol (Phila); 2017; 6(3):283-289. PubMed ID: 28558176
[TBL] [Abstract][Full Text] [Related]
7. How we diagnose and treat vitreoretinal lymphoma.
Fend F; Ferreri AJ; Coupland SE
Br J Haematol; 2016 Jun; 173(5):680-92. PubMed ID: 27133587
[TBL] [Abstract][Full Text] [Related]
8. Intraocular lymphoma.
Chan CC; Buggage RR; Nussenblatt RB
Curr Opin Ophthalmol; 2002 Dec; 13(6):411-8. PubMed ID: 12441846
[TBL] [Abstract][Full Text] [Related]
9. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
11. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
Hashida N; Nakai K; Saitoh N; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
[TBL] [Abstract][Full Text] [Related]
12. [Research progress in the diagnosis of primary vitreoretinal lymphoma].
Tuo YR; Zhang MF
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):954-959. PubMed ID: 37936364
[TBL] [Abstract][Full Text] [Related]
13. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
14. Primary vitreoretinal lymphoma: an update on pathogenesis, diagnosis and treatment.
Reichstein D
Curr Opin Ophthalmol; 2016 May; 27(3):177-84. PubMed ID: 26859131
[TBL] [Abstract][Full Text] [Related]
15. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
[TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnostics for vitreoretinal lymphoma].
Bonzheim I; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):150-154. PubMed ID: 37947807
[TBL] [Abstract][Full Text] [Related]
17. Presentation, Diagnostic Testing and Initial Treatment of Vitreoretinal Lymphoma.
International Vitreoretinal B-Cell Lymphoma Registry Investigator Group
Ophthalmol Retina; 2024 Jan; 8(1):72-80. PubMed ID: 37648063
[TBL] [Abstract][Full Text] [Related]
18. Clinical review: treatment of vitreoretinal lymphoma.
Pe'er J; Hochberg FH; Foster CS
Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma.
Kimura K; Usui Y; Goto H;
Jpn J Ophthalmol; 2012 Jul; 56(4):383-9. PubMed ID: 22661396
[TBL] [Abstract][Full Text] [Related]
20. Primary vitreoretinal lymphoma.
Kalogeropoulos D; Vartholomatos G; Mitra A; Elaraoud I; Ch'ng SW; Zikou A; Papoudou-Bai A; Moschos MM; Kanavaros P; Kalogeropoulos C
Saudi J Ophthalmol; 2019; 33(1):66-80. PubMed ID: 30930667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
